AI Engines For more Details: Perplexity Kagi Labs You
Antioxidant Properties: Carnosine is a potent antioxidant, meaning it can neutralize harmful free radicals in the body. Free radicals are unstable molecules that can damage cells and contribute to aging and various diseases. By scavenging free radicals, carnosine helps to protect cells from oxidative stress and reduce the risk of oxidative damage to tissues throughout the body.
Anti-glycation Effects: Carnosine has been shown to inhibit the process of glycation, which is the binding of sugar molecules to proteins or lipids. Glycation can lead to the formation of advanced glycation end products (AGEs), which are associated with aging and the development of age-related diseases such as diabetes, Alzheimer's disease, and cardiovascular disease. By inhibiting glycation, carnosine may help to prevent or slow the progression of these diseases.
Neuroprotective Effects: Carnosine has been studied for its potential neuroprotective effects in the brain. It may help to protect neurons from damage caused by oxidative stress, inflammation, and excitotoxicity (excessive stimulation of nerve cells). Some research suggests that carnosine may have potential therapeutic applications in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Muscle Function and Performance: Carnosine plays a role in buffering acid buildup in muscle tissue during high-intensity exercise. By maintaining optimal pH levels in muscle cells, carnosine may help to delay the onset of muscle fatigue and improve exercise performance, particularly during short-duration, high-intensity activities such as sprinting and weightlifting.
Eye Health: Carnosine has been investigated for its potential role in maintaining eye health and preventing age-related vision loss. It may help to protect the retina from oxidative damage and reduce the risk of conditions such as age-related macular degeneration (AMD) and cataracts.
Cardiovascular Health: Some research suggests that carnosine may have beneficial effects on cardiovascular health, including reducing blood pressure, improving lipid metabolism, and protecting against atherosclerosis (hardening of the arteries). These effects may help to reduce the risk of heart disease and stroke.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| 📓 Direct Citations | 👪👶 Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Helicobacter | genus | Decreases |
| 1 | 0 | Helicobacter pylori | species | Decreases |
| 0 | 1 | Helicobacter pylori 25 | strain | Decreases |
| 0 | 1 | Helicobacter pylori 26695 | strain | Decreases |
| 0 | 1 | Helicobacter pylori 908 | strain | Decreases |
| 0 | 1 | Helicobacter pylori F32 | strain | Decreases |
| 0 | 1 | Helicobacter pylori Lithuania75 | strain | Decreases |
| 0 | 1 | Helicobacter pylori oki112 | strain | Decreases |
| 0 | 1 | Helicobacter pylori oki828 | strain | Decreases |
| 0 | 1 | Helicobacter pylori SouthAfrica20 | strain | Decreases |
| 0 | 1 | Helicobacter pylori v225d | strain | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 0.5 | 0.5 | |
| Alopecia (Hair Loss) | 0.5 | 0.5 | |
| Alzheimer's disease | 0.9 | 0.9 | |
| Ankylosing spondylitis | 0.4 | -0.4 | |
| Antiphospholipid syndrome (APS) | 0.5 | 0.5 | |
| Atherosclerosis | 0.9 | 0.9 | |
| Atrial fibrillation | 0.5 | 0.5 | |
| Autoimmune Disease | 0.5 | 0.5 | |
| Barrett esophagus cancer | 0.5 | 0.5 | |
| Celiac Disease | 0.9 | 0.9 | |
| Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | |
| Colorectal Cancer | 0.9 | 0.9 | |
| Coronary artery disease | 0.5 | 0.5 | |
| COVID-19 | 0.4 | 0.4 | |
| deep vein thrombosis | 0.5 | 0.5 | |
| Eosinophilic Esophagitis | 0.5 | 0.5 | |
| erectile dysfunction | 0.5 | 0.5 | |
| Fibromyalgia | 0.5 | 0.5 | |
| Functional constipation / chronic idiopathic constipation | 0.5 | 0.5 | |
| gallstone disease (gsd) | 0.4 | 0.4 | |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.5 | 0.4 | 0.25 |
| Gout | 0.5 | 0.4 | 0.25 |
| Graves' disease | 0.5 | 0.5 | |
| Halitosis | 0.5 | 0.5 | |
| Hashimoto's thyroiditis | 0.5 | 0.5 | |
| Heart Failure | 0.5 | 0.5 | |
| hyperglycemia | 0.4 | 0.4 | |
| Hyperlipidemia (High Blood Fats) | 0.4 | 0.4 | |
| Hypothyroidism | 0.5 | 0.5 | |
| IgA nephropathy (IgAN) | 0.5 | 0.5 | |
| Inflammatory Bowel Disease | 0.5 | 0.5 | |
| Irritable Bowel Syndrome | 0.5 | 0.5 | |
| ischemic stroke | 0.5 | 0.5 | |
| Mast Cell Issues / mastitis | 0.5 | 0.5 | |
| Metabolic Syndrome | 0.5 | 0.5 | |
| Neuropathy (all types) | 0.4 | 0.4 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.9 | 0.9 | |
| Obesity | 0.9 | 0.9 | |
| Osteoporosis | 0.4 | 0.4 | |
| Parkinson's Disease | 0.5 | 0.5 | |
| Psoriasis | 0.5 | 0.5 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.4 | 0.4 | |
| Rosacea | 0.5 | 0.5 | |
| Type 1 Diabetes | 0.5 | 0.5 | |
| Ulcerative colitis | 0.5 | 0.5 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
